As expected, LRP2 was highly expressed in tumors that arise from absorptive epithelia, such as clear cell renal cell carcinoma, papillary renal cell carcinoma, mesothelioma, invasive breast carcinoma, and papillary thyroid cancer. This evidence concerns the gene LRP2 and invasive breast carcinoma.